|
|
Volumn 4, Issue SUPPL. 3, 2004, Pages
|
|
New perspectives with antimetabolites in the management of breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTIMETABOLITE;
CAPECITABINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIRUBICIN;
FLUOROURACIL;
GEMCITABINE;
METHOTREXATE;
PACLITAXEL;
TAXANE DERIVATIVE;
TRASTUZUMAB;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CELL CYCLE G1 PHASE;
CELL CYCLE G2 PHASE;
CLINICAL TRIAL;
CROSS RESISTANCE;
CYTOTOXICITY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
HUMAN;
HYPOTHESIS;
|
|
EID: 1642279634
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.3816/CBC.2004.s.001 Document Type: Editorial |
|
Times cited : (1)
|
|
References (1)
|
